We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
-8.7%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$394M
AUM Growth
-$61.6M
Cap. Flow
+$9.46M
Cap. Flow %
2.4%
Top 10 Hldgs %
41.57%
Holding
559
New
66
Increased
101
Reduced
108
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 9.05%
2 Healthcare 5.17%
3 Financials 4.79%
4 Utilities 4.37%
5 Energy 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACB
501
Aurora Cannabis
ACB
$175M
$0 ﹤0.01%
19
+17
+850% +$426
AEMD icon
502
Aethlon Medical
AEMD
$1.75M
0
AMC icon
503
AMC Entertainment Holdings
AMC
$2.55B
$0 ﹤0.01%
1
APTV icon
504
Aptiv
APTV
$11.9B
-19
Closed -$2K
ASIX icon
505
AdvanSix
ASIX
$541M
$0 ﹤0.01%
12
-3
-20% -$134
AYI icon
506
Acuity Brands
AYI
$10B
-250
Closed -$47K
CNX icon
507
CNX Resources
CNX
$5.32B
$0 ﹤0.01%
25
COR icon
508
Cencora
COR
$60.4B
-35
Closed -$5K
CRON
509
Cronos Group
CRON
$1.06B
$0 ﹤0.01%
+75
New +$234
DEO icon
510
Diageo
DEO
$49.1B
-250
Closed -$51K
DXC icon
511
DXC Technology
DXC
$1.8B
$0 ﹤0.01%
5
GNRC icon
512
Generac Holdings
GNRC
$12B
$0 ﹤0.01%
2
GSK icon
513
GSK
GSK
$102B
-16
Closed -$1K
GTX icon
514
Garrett Motion
GTX
$5.71B
$0 ﹤0.01%
33
-6
-15% -$41
ICE icon
515
Intercontinental Exchange
ICE
$85B
$0 ﹤0.01%
5
ITT icon
516
ITT
ITT
$17.7B
-500
Closed -$38K
JAZZ icon
517
Jazz Pharmaceuticals
JAZZ
$15.8B
$0 ﹤0.01%
2
KD icon
518
Kyndryl
KD
$3.1B
$0 ﹤0.01%
30
+11
+58% +$128
LE icon
519
Lands' End
LE
$378M
$0 ﹤0.01%
15
NI icon
520
NiSource
NI
$21.3B
$0 ﹤0.01%
2
NIO icon
521
NIO
NIO
$12.1B
$0 ﹤0.01%
+11
New +$202
NOK icon
522
Nokia
NOK
$52.4B
-13
Closed
NWL icon
523
Newell Brands
NWL
$2.65B
-252
Closed -$5K
PHM icon
524
Pultegroup
PHM
$24.3B
-121
Closed -$5K
PJT icon
525
PJT Partners
PJT
$4.31B
-6
Closed

Similar funds

Vectors Research Management's Q2 2022 Portfolio in Review

As of Q2 2022, Vectors Research Management held 559 positions worth $394M, down 14% from $456M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Vectors Research Management's Q2 2022 filing shows 66 new, 101 increased, 108 reduced and 35 closed positions. Its largest new stake was Textron: 6,192 shares worth $378K. The largest sale was State Street SPDR S&P Bank ETF, an estimated $5.14M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

  • Vectors Research Management's largest Q2 2022 buy was Textron: 6,192 shares worth $378K.
  • Vectors Research Management added most to Vanguard Morningstar Small-Cap ETF in Q2 2022, an estimated $28.6M increase.
  • Vectors Research Management's biggest Q2 2022 reduction was State Street SPDR S&P Bank ETF, cutting an estimated $5.14M.
  • Vectors Research Management fully exited Diageo in Q2 2022, selling an estimated $51K.
  • Vectors Research Management's ten largest holdings make up 42% of its $394M portfolio in Q2 2022.
  • Vectors Research Management opened 66 new positions and closed 35 in Q2 2022.
  • Vectors Research Management's portfolio value fell 14% quarter-over-quarter to $394M.

Based on Vectors Research Management's 13F filing for Q2 2022, filed 12 Aug 2022.